Original article | Volume 33, Article 187, 11 Jul 2019 | 10.11604/pamj.2019.33.187.18295

Esophageal cancer in Mozambique: should mycotoxins be a concern?

Jotamo Come, Edgar Cambaza, Rita Ferreira, José Manuel Correia da Costa, Carla Carrilho, Lúcio Lara Santos

Corresponding author: Lúcio Lara Santos, Experimental Pathology and Therapeutics Research Group, Surgical Oncology Department, Portuguese Oncology Institute, Porto, Portugal, ONCOCIR, Education and Care in Oncology, Lusophone Africa

Received: 28 Jan 2019 - Accepted: 04 May 2019 - Published: 11 Jul 2019

Domain: Food protection,Cancer epidemiology

Keywords: Mycotoxyns, esophageal cancer, Mozambique

©Jotamo Come et al. Pan African Medical Journal (ISSN: 1937-8688). This is an Open Access article distributed under the terms of the Creative Commons Attribution International 4.0 License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Cite this article: Jotamo Come et al. Esophageal cancer in Mozambique: should mycotoxins be a concern?. Pan African Medical Journal. 2019;33:187. [doi: 10.11604/pamj.2019.33.187.18295]

Available online at: https://www.panafrican-med-journal.com/content/article/33/187/full

Home | Volume 33 | Article number 187

Original article

Esophageal cancer in Mozambique: should mycotoxins be a concern?

Esophageal cancer in Mozambique: should mycotoxins be a concern?

Jotamo Come1, Edgar Cambaza2, Rita Ferreira3, José Manuel Correia da Costa4, Carla Carrilho5, Lúcio Lara Santos6,7,&

 

1Department of Surgery, Maputo Central Hospital, Maputo, Mozambique, 2Department of Biological Sciences, Faculty of Sciences, Eduardo Mondlane University, Maputo, Mozambique, 3QOPNA-Química Orgânica, Produtos Naturais e Agroalimentares, Departamento de Química, Aveiro University, Aveiro, Portugal, 4Center for the Study of Animal Science, ICETA, University of Porto and INSA-National Health Institute Dr. Ricardo Jorge, Porto, Portugal, 5Department of Pathology, Faculty of Medicine, Eduardo Mondlane University, Maputo Central Hospital, Maputo, Mozambique, 6Experimental Pathology and Therapeutics Research Group, Surgical Oncology Department, Portuguese Oncology Institute, Porto, Portugal, 7ONCOCIR, Education and Care in Oncology, Lusophone Africa

 

 

&Corresponding author
Lúcio Lara Santos, Experimental Pathology and Therapeutics Research Group, Surgical Oncology Department, Portuguese Oncology Institute, Porto, Portugal, ONCOCIR, Education and Care in Oncology, Lusophone Africa

 

 

Abstract

Fumonisin B1 (FB1) is a mycotoxin frequently found in agricultural commodities. The toxin poses a considerable risk for human and animal health. FB1 is among several mycotoxins produced by Fusarium spp. contaminating virtually any cereal and other Poaceae. Their intracellular action includes the promotion of oxidative stress through the generation of reactive oxygen species (ROS) that damage biomolecules such as DNA. These toxic effects were observed in vivo and in vitro. However, the association between esophageal lesions and oxidative stress induced by FB1. Studies in China, Iran and South Africa showed higher exposure to fumonisins in areas with higher risk of esophageal cancer (EC). Exposure to mycotoxins may be inevitable in Mozambique. How mycotoxins, particularly fumonisins from the contaminated food, can be associated with the emergence of EC in Mozambique? Herein, we revise the literature and present some pieces of evidence in order to highlight the burden of mycotoxins and to provide evidence-based considerations for the stakeholders involved in the management of the EC agenda in Mozambique. The information presented herein supports the need to implement novel and/or to revisit the existent detoxification methods to reduce the global burden of mycotoxins and its outcomes in health management.

 

 

Essay    Down

Cancer of esophagus is a serious health problem in sub-Saharan Africa and it is associated with high lethality [1]. Carcinogenesis of esophageal cancer (EC) is still largely unknown in sub-Saharan Africa. Several individual factors have been considered but the main cause is most likely multifactorial [2]. EC, mainly squamous cell carcinoma, is highly prevalent in Western Kenya, especially among members of the Kalenjin community, who reside in the northern and southern areas of the rift valley [3]. According to Kigen et al. (2017), the most plausible causes of the high incidence of EC among the Kalenjin community are mycotoxins, particularly fumonisins from the food chain resulting from poor handling of cereals [4]. Aflatoxins and fumonisins are mycotoxins contaminating a large fraction of the world's food, including maize, cereals, groundnuts and tree nuts [5]. Contamination is due to high-level chronic exposure [6]. This is particularly true in subsistence farming communities where regulations to control exposure are either non-existent or practically unenforceable [7].

 

Esophageal cancer in Mozambique

 

Mozambique has a high rate of EC. According to previous studies, EC is the 4th most incident malignant tumor in Maputo in both genders [8]. A study of 522 consecutive cases of EC diagnosed and treated at the Maputo Central Hospital revealed that most patients were female (n=291, 55.7%), and born in the southern region of the country (n=418, 80.1%) where the consumption of maize in food and in fermented beverages is high [9]. The prognosis is highly undesirable as the median survival time was 3.5 months for all patients [9]. Therefore, it is necessary to implement a nationwide esophageal cancer program in Mozambique encompassing the detection of risk factors and the implementation of early diagnosis programs. Can mycotoxins play a role in the malignant transformation process of the esophagus in Mozambique? Kigen et al. (2017) suggest that mycotoxins, particularly fumonisins, combined with traditional alcohol, dietary deficiencies and viral infections acting synergistically are risk factors for EC in the Western Kenya [4]. So, one can suspect of a similar effect in Mozambique once food habits are similar.

 

Fusarium verticillioides and carcinogenesis

 

Fusarium verticillioides, a mold that grows mostly on maize, has the ability to produce Fumonisin B1 (FB1). FB1 is a toxic secondary metabolite linked to EC and neural tube defects in humans and lung edema in swine and leukoencephalomalacia in equines [10]. Their intracellular action, favouring oxidative stress and the generation of reactive oxygen species (ROS), sustain their toxic effects observed in vivo [11,12] and in vitro [13,14]. Mycotoxins have a strong tendency and ability to penetrate the human and animal cells and reach the cellular genome where it causes a major mutagenic change in the nucleotide sequence, which leads to strong and permanent defects in the genome (adduct formation targeting guanine bases, which induces G→T transversions at codon 249 in TP53) [15,16]. FB1 might also disrupt sphingolipid metabolism therefore impairing the balance between apoptosis and mitosis [17]. These defects will eventually be transcribed, translated and lead to the development of cancer (Figure 1). FB1 is a known animal carcinogen and has been shown to cause tumors of the liver and kidney in mice and rats [18]. Likewise, chronic dietary exposure to FB1 (≥50 ppm) is carcinogenic to rodents: hepatocarcinogenic in male BD IX rats and female B6C3F1 mice and nephrocarcinogenic in male F344 rats [19,20]. The weight of evidence indicates that the mechanism of carcinogenesis is epigenetic and related to compensatory cell proliferation accompanying apoptosis [21]. Fumonisin was categorized as a Group 2B carcinogen by the International Agency for Research on Cancer (CIRC) [22].

 

Fumonisins and esophageal cancer

 

So far, evidence for human carcinogenicity of fumonisins is circumstantial and limited. Yet, studies in China, Iran, and South Africa showed higher exposure to fumonisins in areas with higher risk of EC [23]. Consumption of contaminated maize has been associated with an elevated risk of EC in the Transkei region in South Africa and China [24,25]. Maize consumption by different age groups in these communities was measured in Mbizana (formerly known as Bizana) and Centane magisterial areas of the former Transkei region of the eastern cape province of South Africa, an area of high EC incidence [25]. Mean fumonisin exposures in all age groups were above the provisional maximum tolerable daily intake according FAO/WHO Expert Committee on Food Additives. Mwalwayo and Thole (2016) observed that populations in the rural areas of Malawi, where the incidence of EC is also high, may be at a high risk of exposure to unacceptably high levels of aflatoxins and fumonisins, according to the Codex Alimentarius. This seems more preoccupant in the Chikhwawa and Machinga districts from the southern part of the country where relatively high levels of both aflatoxins and fumonisins were observed [26]. This region is bordered by Mozambique. However, the only case-control study on fumonisin exposure in relation to EC risk was conducted in Linxian, China, and no association between exposure and risk was found [27]. Urinary fumonisin B1 (UFB1) was the exposure biomarker assayed once it offers an integrated estimation of exposure from all sources for either aflatoxin or fumonisin [5]; however, the results were inconclusive. UFB1 has been measured in human samples in regions with known high exposure to dietary fumonisins [28]. In general, statistically significant relationships between UFB1 and either estimated or measured FB1 intakes were reported; however, the data indicate that urinary measure was only moderately reflective of the intake level [29]. According to Liu et al. (2016), mutation analysis revealed common signatures across esophageal cancer samples from Malawi patients associated with aging, cytidine deaminase activity, and a third signature of unknown origin. Signatures of mycotoxins were notably absent [30]. Therefore, epidemiologic studies are needed to establish or refute any association between fumonisins and EC.

 

Mycotoxin in Mozambique

 

Aflatoxins B1 (AFB1) and G1 (AFG1) have been found in Mozambican commodities, especially groundnuts and maize [31]. Casadei found aflatoxins in food samples from different areas of Mozambique, though it was almost 40 years ago [32]. Yet, more recent evidences reported by Sineque et al. (2017) and Zuza et al. (2018) demonstrate that aflatoxin exposure is still a major issue in Mozambique [33,34]. According to Cambaza et al. (2018a,2018b), the highest prevalence of aflatoxins contamination was found in Nacala, followed by Maputo city. Inhambane and Nampula also had high aflatoxin levels in their foods [31,32]. Warth et al. (2012) studied mycotoxins in food and feed from Burkina Faso and Mozambique and observed that FB1 concentration in maize were higher in Mozambique (92% incidence, median = 869 µg/kg) than in Burkina Faso (81% incidence, median = 269 µg/kg). Their samples were purchased in markets from Nampula city [35]. New strategies for fighting food contamination by mycotoxins are urgently needed [36].

 

The working group from IARC regarding food contamination with fumonisin B1 performed the present evaluation: there is inadequate evidences in humans for the carcinogenicity of fumonisins. However, there is sufficient evidence from experimental animals for the carcinogenicity of FB1. Thus, FB1 is possibly carcinogenic to humans (Group 2B). These subjects are usually exposed to other risk factors among which are indoor air pollution caused by cooking with charcoal. So, the combination of these risk factors may be at the genesis of the high esophageal cancer rates in Mozambique. We believe that it is necessary to study these issues, to educate the population, to move beyond ecological evidence and to promote food security with cost-effective measures.

 

 

Competing interests Up    Down

The authors declare no competing.

 

 

Authors’ contributions Up    Down

LLS was responsible for primary conception and design of the article with input from co-authors. Initial drafts of the article were prepared by LLS, JC, EC. Additions, modifications and revisions critical for important intellectual content of the article were performed by JC, EC, RF, JMC, CC, LLS, including final approval of the version to be published.

 

 

Figures Up    Down

Figure 1: overview of the putative molecular pathways involved in EC induced by FB1. (C-Me - DNA hypermethylation; CYP - cytochrome P450; dG-8-oxo - 8-Oxo-2’-deoxyguanosine; FB1- fumonisin B1; UFB1- urinary fumonisin B1)

 

 

References Up    Down

  1. Cheng ML, Zhang L, Borok M, Chokunonga E, Dzamamala C, Korir A et al. The incidence of oesophageal cancer in Eastern Africa: identification of a new geographic hot spot. Cancer Epidemiol. 2015;39(2):143-9. PubMed | Google Scholar

  2. Kamangar F, Chow WH, Abnet CC, Dawsey SM. Environmental causes of esophageal cancer. Gastroenterol Clin North Am. 2009 Mar;38(1):27-57, vii. PubMed | Google Scholar

  3. Patel K, Wakhisi J, Mining S, Mwangi A, Patel R. Esophageal Cancer, the topmost cancer at MTRH in the rift valley, Kenya, and its potential risk factors. ISRN Oncol. 2013;2013:503249. PubMed | Google Scholar

  4. Kigen G, Busakhala N, Kamuren Z, Rono H, Kimalat W, Njiru E. Factors associated with the high prevalence of oesophageal cancer in Western Kenya: a review. Infect Agent Cancer. 2017;12:59. PubMed | Google Scholar

  5. WHO. Co-exposure of fumonisins with aflatoxins. 2018. Accessed on 28 January 2019.

  6. Wild CP, Gong YY. Mycotoxins and human disease: a largely ignored global health issue. Carcinogenesis. 2010 Jan;31(1):71-82. PubMed | Google Scholar

  7. WHO. Mycotoxin levels in subsistence farming systems in South Africa. 2008. Accessed on 28 January 2019.

  8. Carrilho C, Fontes F, Tulsidás S, Lorenzoni C, Ferro J, Brandão M, Ferro A, Lunet N. Cancer incidence in Mozambique in 2015-2016: data from the Maputo Central Hospital Cancer Registry. Eur J Cancer Prev. 2019;28(4):373-376. PubMed | Google Scholar

  9. Come J, Castro C, Morais A, Cossa M, Modcoicar P, Tulsidás S et al. Clinical and pathologic profiles of esophageal cancer in Mozambique: a study of consecutive patients admitted to Maputo Central Hospital. J Glob Oncol. 2018;4:1-9. PubMed | Google Scholar

  10. Voss KA, Smith GW, Haschek WM. Fumonisins: toxicokinetics, mechanism of action and toxicity. Animal Feed Science and Technology, 2007;137(3-4):299-325. Google Scholar

  11. Osselaere A, Santos R, Hautekiet V, De Backer P, Chiers K, Ducatelle R. Deoxynivalenol impairs hepatic and intestinal gene expression of selected oxidative stress, tight junction and inflammation proteins in broiler chickens, but addition of an adsorbing agent shifts the effects to the distal parts of the small intestine. PLoS One. 2013;8(7):e69014. PubMed | Google Scholar

  12. Abbès S, Ben Salah-Abbès J, Jebali R, Younes RB, Oueslati R. Interaction of aflatoxin B1 and fumonisin B1 in mice causes immunotoxicity and oxidative stress: possible protective role using lacticacid bacteria. J Immunotoxicol. 2016;13(1):46-54. PubMed | Google Scholar

  13. Li D, Ye Y, Lin S, Deng L, Fan X, Zhang Y et al. Evaluation of deoxynivalenol-induced toxic effects on DF-1 cells in vitro: cellcycle arrest, oxidative stress, and apoptosis. Environ Toxicol Pharmacol. 2014 Jan;37(1):141-9. PubMed | Google Scholar

  14. Domijan AM, Gajski G, Novak Jovanovic I, Geric M, Garaj-Vrhovac V. In vitro genotoxicity of mycotoxinochratoxin A and fumonisin B (1) could be prevented by sodium copper chlorophylin-implication to their genotoxic mechanism. Food Chem. 2015;170:455-62. PubMed | Google Scholar

  15. Bennett JW, Klich M. Mycotoxins. Clin Microbiol Rev. 2003;16(3):497-516. PubMed

  16. Barnes JL, Zubair M, John K, Poirier MC, Martin FL. Carcinogens and DNA damage. Biochem Soc Trans. 2018;46(5):1213-1224. PubMed | Google Scholar

  17. Voss KA, Riley RT, Norred WP, Bacon CW, Meredith FI, Howard PC et al. An overview of rodent toxicities: liver and kidney effects of fumonisins and Fusarium moniliforme. Environ Health Perspect. 2001;109 Suppl 2:259-66. PubMed | Google Scholar

  18. Lemmer ER, Vessey CJ, Gelderblom WC, Shephard EG, Van Schalkwyk DJ, Van Wijk RA et al. Fumonisin B1-induced hepatocellular and cholangiocellular tumors in male Fischer 344 rats: potentiating effects of 2-acetylaminofluorene on oval cell proliferation and neoplastic development in a discontinued feeding study. Carcinogenesis. 2004;25(7)1257-1264. PubMed

  19. Gelderblom WC, Kriek NP, Marasas WF, Thiel PG. Toxicity and carcinogenicity of the fusarium moniliforme metabolite, fumonisin B1, in rats. Carcinogenesis. 1991;12(7):1247-51. PubMed | Google Scholar

  20. Howard PC, Eppley RM, Stack ME, Warbritton A, Voss KA, Lorentzen RJ. Fumonisin b1 carcinogenicity in a two-year feeding study using F344 rats and B6C3F1 mice. Environ Health Perspect. 2001;109 Suppl 2:277-82. PubMed | Google Scholar

  21. Huang D, Cui L, Sajid A, Zainab F, Wu Q, Wang X et al. The epigenetic mechanisms in fusarium mycotoxins induced toxicities. Food Chem Toxicol. 2019;123:595-601. PubMed | Google Scholar

  22. Domijan AM. Fumonisin B(1): a neurotoxic mycotoxin. Arh Hig Rada Toksikol. 2012;63(4):531-44. PubMed | Google Scholar

  23. Braun MS, Wink M. Exposure, occurrence, and chemistry of fumonisins and their cryptic derivatives. Comprehensive Reviews in Food Science and Food Safety. 2018;17(3):769-791. Google Scholar

  24. Williams JH, Grubb JA, Davis JW, Wang JS, Jolly PE, Ankrah NA. Phillips HIV and hepatocellular and esophageal carcinomas related to consumption of mycotoxin-prone foods in sab-Saharan Africa. Am J Clin Nutr. 2010;92(1):154-60. PubMed | Google Scholar

  25. Shephard GS, Marasas WF, Burger HM, Somdyala NI, Rheeder JP, Van der Westhuizen L et al. Exposure assessment for fumonisins in the former Transkei region of South Africa. Food Addit Contam. 2007;24(6):621-9. PubMed | Google Scholar

  26. Daniel SM, Bernard T. Prevalence of aflatoxin and fumonisins (B1 + B2) in maize consumed in rural Malawi. Toxicology reports. 2016;3:173-179. Google Scholar

  27. Abnet CC, Borkowf CB, Qiao YL, Albert PS, Wang E, Merrill AH Jr et al. Sphingolipids as biomarkers of fumonisin exposure and risk of esophageal squamous cell carcinoma in china. Cancer Causes Control. 2001;12(9):821-8. PubMed | Google Scholar

  28. Chen C, Mitchell NJ, Gratz J, Houpt ER, Gong Y, Egner PA et al. Exposure to aflatoxin and fumonisin in children at risk for growth impairment in rural Tanzania. Environ Int. 2018;115:29-37. PubMed | Google Scholar

  29. Torres O, Matute J, Gelineau-van Waes J, Maddox JR, Gregory SG, Ashley-Koch AE et al. Urinary fumonisin B1 and estimated fumonisin intake in women from high- and low-exposure communities in Guatemala. Mol Nutr Food Res. 2014;58(5):973-83. PubMed | Google Scholar

  30. Liu W, Snell JM, Jeck WR, Hoadley KA, Wilkerson MD, Parker JS et al. Subtyping sub-Saharan esophageal squamous cell carcinoma by comprehensive molecular analysis. JCI Insight. 2016;1(16):e88755. PubMed | Google Scholar

  31. Edgar C, Shigenobu K, Shuso K. Aflatoxins in Mozambique: impact and potential for intervention. Agriculture. 2018;8(7):100. Google Scholar

  32. Edgar C, Shigenobu K, Shuso K. Aflatoxins in Mozambique: etiology, epidemiology and control. Agriculture. 2018;8(7)1-87. Google Scholar

  33. Sineque AR, Macuamule CL, Dos Anjos FR. Aflatoxin B1 contamination in chicken livers and gizzards from industrial and small abattoirs, measured by ELISA technique in Maputo, Mozambique. Int J Environ Res Public Health. 2017;14(9). pii: E951. PubMed | Google Scholar

  34. Zuza E, Mondjana A, Muitia A, Amane M. Effects of harvesting date on aflatoxin contamination in groundnuts in northern mozambique. Fifth RUFORUM Biennial Regional Conference. 2016;14(3):167-172. Google Scholar

  35. Warth B, Parich A, Atehnkeng J, Bandyopadhyay R, Schuhmacher R, Sulyok M et al. Quantitation of mycotoxins in food and feed from Burkina Faso and Mozambique using a modern LC-MS/MS multitoxin method. J Agric Food Chem. 2012;60(36):9352-63. PubMed | Google Scholar

  36. News Focus. Breaking the mold: new strategies for fighting aflatoxins. 2013. Accessed on 28 January 2019.

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

Original article

Esophageal cancer in Mozambique: should mycotoxins be a concern?

Original article

Esophageal cancer in Mozambique: should mycotoxins be a concern?

Original article

Esophageal cancer in Mozambique: should mycotoxins be a concern?